Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis

Acta Oto-Laryngologica

Volumn 124, Issue 5, 2004, Pages 603-607

  Marioni, Gino ^a   Perin, Norberto ^a   Tregnaghi, Alberto ^a   Bellemo, Barbara ^a   Staffieri, Alberto ^a   De Filippis, Cosimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Blood inner ear barrier; Chronic treatment; Cyclosporin A; Hearing loss; Ototoxicity

Indexed keywords

AZATHIOPRINE; BETAHISTINE; CYCLOSPORIN A; MEPREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; AUDIOLOGY; BONE MARROW TRANSPLANTATION; CADAVER DONOR; CASE REPORT; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FOCAL GLOMERULOSCLEROSIS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NEUROTOXICITY; ORGAN TRANSPLANTATION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY;

ACOUSTIC IMPEDANCE TESTS; ADULT; AUDIOMETRY, EVOKED RESPONSE; AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; AUDITORY THRESHOLD; COCHLEA; CYCLOSPORINE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEARING LOSS, BILATERAL; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE;

EID: 3042822500     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410016225     Document Type: Article

References (19)

1. Dawson DG, Trobe JD. Blindness after liver transplant. Surv Ophthalmol 2002; 47: 387-91.
2. Porges Y, Blumen S, Fireman Z, Sternberg A, Zamir D. Cyclosporine-induced optic neuropathy, ophthalmoplegia, and nystagmus in a patient with Crohn's disease. Am J Ophthalmol 1998; 126: 607-9.
3. Gopal AK, Thorning DR, Back AL. Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings. Bone Marrow Transplant 1999; 23: 191-3.
4. Trullemans F, Grignard F, Van Camp B, Schots R. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 2001; 67: 94-9.
5. Deutsch ES, Bartling V, Lawenda B, Schwegler J, Folkenstein K, Dunn S. Sensorineural hearing loss in children after liver transplantation. Arch Otolaryngol Head Neck Surg 1998; 124: 529-33.
6. Vasquez EM, Maddux MS, Sanchez J, Pollak R. Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin. Arch Intern Med 1993; 153: 879-82.
7. Hartnick CJ, Cohen AF, Smith RV. Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3). Ann Otol Rhinol Laryngol 1997; 106: 640-2.
8. Hartnick CJ, Smith RV, Tellis V, Greenstein S, Ruben RJ. Reversible sensorineural hearing loss following administration of muromonab-CD3 (OKT3) for cadaveric renal transplant immunosuppression. Ann Otol Rhinol Laryngol 2000; 109: 45-7.
9. Pihusch R, Holler E, Mühlbayer D, Göhring P, Stötzer O, Pihusch M, et al. The impact of antithymocyte globulin on short-term toxicity after allogenic stem cell transplantation. Bone Marrow Transplant 2002; 30: 347-54.
10. Vural A, Onder T, Tanboga H. A case of sudden deafness probably due to antithymocyte globulin treatment. Nephron 1995; 69: 345.
11. Flynn JT, Bunchman TE, Sherbotie JR. Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation. Pediatr Transplant 2001; 5: 439-46.
12. Min DI, Ku YM, Rayhill S, Corwin C, Wu YM, Hunsicker LG. Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient. Pharmacotherapy 1999; 19: 891-3.
13. Saito T, Zhang Z-J, Tokuriki M, Ohtsubo T, Shimabori Y, Yamamoto T, et al. Doxorubicin ototoxicity is induced by combination treatment with cyclosporin A. Acta Otolaryngol 2001; 121: 787-93.
14. Cole E, Keown P, Landsberg D, Halloran P, Shoker A, Rush D, et al. Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow up in stable renal transplant recipients. Transplantation 1998; 65: 505-10.
15. Arinsoy T, Akpolat T, Ataman M, Arik N, Sungur C, Yasavul Ü, et al. Sudden hearing loss in a cyclosporin-treated renal transplantation patient. Nephron 1993; 63: 116-7.
16. Sgro MD, Barozzino T, Mirghani HM, Sermer M, Moscato L, Akouri H, et al. Pregnancy outcome post renal transplantation. Teratology 2002; 65: 5-9.
17. Hegarty JL, Patel S, Fischbein N, Jackler RK, Lalwani AK. The value of the enhanced magnetic resonance imaging in the evaluation of endocochlear disease. Laryngoscope 2002; 112: 8-17.
18. Zhang Z-J, Saito T, Kimura Y, Sugimoto C, Ohtsubo T, Saito H. Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood-inner ear barrier in mice. Brain Res 2000; 852: 116-26.
19. Saito T, Zhang Z-J, Tokuriki M, Ohtsubo T, Shimabori Y, Yamamoto T, et al. Cyclosporine A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin. Brain Res 2001; 901: 265-70.